0001290929-23-000005.txt : 20230119
0001290929-23-000005.hdr.sgml : 20230119
20230119143758
ACCESSION NUMBER: 0001290929-23-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221031
FILED AS OF DATE: 20230119
DATE AS OF CHANGE: 20230119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wolf James G.
CENTRAL INDEX KEY: 0001419248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09974
FILM NUMBER: 23537075
MAIL ADDRESS:
STREET 1: 105, FLYWAY DRIVE
CITY: KIAWAH ISLAND
STATE: SC
ZIP: 29455
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZO BIOCHEM INC
CENTRAL INDEX KEY: 0000316253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 132866202
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
BUSINESS PHONE: 5167555500
MAIL ADDRESS:
STREET 1: ENZO BIOCHEM INC
STREET 2: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-10-31
0
0000316253
ENZO BIOCHEM INC
ENZ
0001419248
Wolf James G.
105, FLYWAY DRIVE
KIAWAH ISLAND
SC
29455
0
0
1
0
Common Stock, $0.01 par value
2022-11-17
4
C
0
300
2.5
A
3535300
D
Common Stock, $0.01 par value
2022-11-21
4
C
0
24700
2.5
A
3560000
D
Common Stock, $0.01 par value
2022-12-14
4
C
0
136200
2.5
A
3696200
D
Common Stock, $0.01 par value
2022-12-15
4
C
0
85100
2.5
A
3781300
D
Common Stock, $0.01 par value
2022-12-16
4
C
0
33700
2.5
A
3815000
D
Common Stock, $0.01 par value
2022-11-01
4
P
0
5000
2.14
A
400500
I
See Footnote
Common Stock, $0.01 par value
2022-10-31
4
P
0
14500
2.15
A
415000
I
See Footnote
Common Stock, $0.01 par value
2022-11-01
4
P
0
3500
2.15
A
418500
I
See Footnote
Long Call Option (right to buy)
2.5
2022-11-01
4
P
0
500
0.44
A
2022-11-01
2023-01-20
Common Stock, $0.01 par value
50000
3250
D
Short Put Option (obligation to buy)
2.5
2022-11-01
4
S
0
500
0.69
A
2022-11-01
2023-01-20
Common Stock, $0.01 par value
50000
4500
D
Short Put Option (obligation to buy)
2.5
2022-11-01
4
S
0
10
0.8
A
2022-11-01
2023-04-21
Common Stock, $0.01 par value
10000
310
D
Long Call Option (right to buy)
2.5
2022-11-01
4
P
0
10
0.65
A
2022-11-01
2023-04-21
Common Stock, $0.01 par value
10000
760
D
Short Put Option (obligation to buy)
2.5
2022-11-01
4
S
0
490
0.8
A
2022-11-01
2023-04-21
Common Stock, $0.01 par value
49000
800
D
Long Call Option (right to buy)
2.5
2022-11-01
4
P
0
490
0.65
A
2022-11-01
2023-04-21
Common Stock, $0.01 par value
49000
1250
D
Long Call Option (right to buy)
2.5
2022-11-03
4
P
0
250
0.42
A
2022-11-03
2023-04-21
Common Stock, $0.01 par value
25000
1050
D
Short Put Option (obligation to buy)
2.5
2022-11-03
4
S
0
250
0.62
A
2022-11-03
2023-04-21
Common Stock, $0.01 par value
25000
1050
D
Short Put Option (obligation to buy)
2.5
2022-11-03
4
S
0
200
0.64
A
2022-11-03
2023-04-21
Common Stock, $0.01 par value
20000
1250
D
Long Call Option (right to buy)
2.5
2022-11-03
4
P
0
200
0.44
A
2022-11-03
2023-04-21
Common Stock, $0.01 par value
20000
1700
D
Short Put Option (obligation to buy)
2.5
2022-11-03
4
S
0
9
0.3
A
2022-11-03
2022-11-18
Common Stock, $0.01 par value
900
248
D
Short Put Option (obligation to buy)
2.5
2022-11-03
4
S
0
2
0.6
A
2022-11-03
2022-11-18
Common Stock, $0.01 par value
200
250
D
Short Put Option (obligation to buy)
2.5
2022-11-17
4
C
0
3
0
D
2022-11-03
2022-11-18
Common Stock, $0.01 par value
300
247
D
Short Put Option (obligation to buy)
2.5
2022-11-21
4
C
0
247
0
D
2022-11-03
2022-11-18
Common Stock, $0.01 par value
24700
0
D
Long Call Option (right to buy)
2.5
2022-12-05
4
S
0
200
0.25
D
2022-12-05
2023-04-21
Common Stock, $0.01 par value
20000
1500
D
Long Call Option (right to buy)
2.5
2022-12-05
4
S
0
57
0.2
D
2022-12-05
2023-04-21
Common Stock, $0.01 par value
5700
1443
D
Long Call Option (right to buy)
2.5
2022-12-06
4
S
0
443
0.15
D
2022-12-06
2023-04-21
Common Stock, $0.01 par value
44300
1000
D
Short Put Option (obligation to buy)
2.5
2022-12-14
4
C
0
1362
0
D
2022-11-01
2023-01-20
Common Stock, $0.01 par value
136200
3138
D
Short Put Option (obligation to buy)
2.5
2022-12-15
4
C
0
851
0
D
2022-11-01
2023-01-20
Common Stock, $0.01 par value
85100
2287
D
Short Put Option (obligation to buy)
2.5
2022-12-15
4
S
0
56
1.25
A
2022-12-15
2023-04-21
Common Stock, $0.01 par value
5600
1306
D
Short Put Option (obligation to buy)
2.5
2022-12-15
4
S
0
444
1.29
A
2022-12-15
2023-04-21
Common Stock, $0.01 par value
44400
1750
D
Short Put Option (obligation to buy)
2.5
2022-12-16
4
C
0
337
0
D
2022-11-01
2023-04-21
Common Stock, $0.01 par value
33700
1413
D
Long Call Option (right to buy)
2.5
2022-12-30
4
S
0
6
0.05
D
2022-12-30
2023-01-20
Common Stock, $0.01 par value
600
3244
D
The counterparty to certain of the Reporting Person's outstanding short put options exercised such options and the Reporting Person was obliged to purchase these shares at an exercise price of $2.50 per share.
This transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for the purpose of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
The transaction was completed in the name and for the benefit of one or more of the Reporting Person's adult children. The Reporting Person maintains power of attorney granted by each of his adult children with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his adult children. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act or 1934, as amended, or for any other purpose.
The 418,500 shares owned indirectly by the Reporting Person upon completion of this Transaction included 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse, 110,000 shares owned directly by the Reporting Person's sibling and 170,500 shares owned directly by adult children of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest.
James G. Wolf
2022-01-19